Article info

Download PDFPDF

Viewpoint
Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shift

Authors

  • Katerina Chatzidionysiou First Department of Propaedeutic and Internal Medicine and Joined Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece PubMed articlesGoogle scholar articles
  • Petros P Sfikakis First Department of Propaedeutic and Internal Medicine and Joined Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Laikon Hospital, Athens, Greece PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Katerina Chatzidionysiou; aikaterini.chatzidionysiou{at}ki.se
View Full Text

Citation

Chatzidionysiou K, Sfikakis PP
Low rates of remission with methotrexate monotherapy in rheumatoid arthritis: review of randomised controlled trials could point towards a paradigm shift

Publication history

  • Received April 23, 2019
  • Revision received June 26, 2019
  • Accepted June 29, 2019
  • First published July 27, 2019.
Online issue publication 
July 27, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.